onyx pharmaceuticals inc
(ONXX:NASDAQ GS)

Executive Profile*

Background*

Mr. Matthew K. Fust has been Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Onyx Pharmaceuticals, Inc. since January 5, 2009. Mr. Fust served as Chief Financial Officer of Jazz pharmaceuticals Inc. from May 2003 to December 31, 2008, Executive Vice President from March 2008 to December 31, 2008, Principal Accounting Officer until December 31, 2008 and Senior Vice President since 2004. Mr. Fust joined Jazz Pharmaceuticals in 2003. ... Mr. Fust served as Chief Financial Officer of Perlegen Sciences, Inc. from May 2002 to May 2003. Mr. Fust served as Senior Vice President and Chief Financial Officer of ALZA Corporation from 1996 to January 2002. At ALZA, he was responsible for the accounting, financial planning, information technology, internal audit, tax and treasury functions and served as its Vice President, Finance and Controller from 1998 to 1999 and an Executive Director (Accounting and Financial Reporting) from 1996 to 1998. From 1991 to 1996, Mr. Fust was a Manager in the healthcare strategy practice at Anderson Consulting. Before joined ALZA, he was a Management Consultant in Andersen Consultant’s healthcare strategy practice for five years. Mr. Fust has been an Independent Director of Sunesis Pharmaceuticals Inc. since May 2005 and serves as a Director of Project Inform, a nonprofit corporation. Mr. Fust holds an MBA from the Graduate School of Business at Stanford University and a Bachelor of Arts in Accounting degree from the University of Minnesota.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ONXX:US	$94.73 USD	+1.82

COMPETITOR COMPENSATION